Jeff Craven

February 14, 2019 | Rheumatology News Other factors likely explain decreased rate of joint replacement FROM RHEUMATOLOGY

April 23, 2020 | Rheumatology News An international registry of adult and pediatric rheumatology patients is beginning to identify trends in the types of patients with COVID-19 and who is recovering.

The more than 130 comments responding to the US Food and Drug Administration@s (FDA) draft guidance on clinical trial diversity were largely positive, with stakeholders wanting more information on the types of studies that require a Diversity Action Plan (DAP), alignment on data collection categories for demographics, applicability of DAP requirements to global trials, and what happens if sponsors fail to meet the outlined DAP requirements.

Of the 30% of new drugs approved between 2015 and 2021 with pediatric trial requirements under the Pediatric Research Equity Act (PREA), more than half had ongoing studies at a median of 5.6 years of follow-up, according to a recent research letter published in JAMA.

December 13, 2018 | Dermatology FROM JOURNAL OF PSORIASIS AND PSORIATIC ARTHRITIS

The US Food and Drug Administration (FDA) has released a new draft guidance describing what should and should not be included in the Drug Interactions (DIs) section for human prescription drug and biological product labeling as well as how drug interaction information should appear in other areas of the product@s labeling.

April 23, 2020 | Dermatology An international registry of adult and pediatric rheumatology patients is beginning to identify trends in the types of patients with COVID-19 and who is recovering.

August 5, 2019 | Oncology Practice FROM JAMA INTERNAL MEDICINE

March 5, 2019 | Oncology Practice REPORTING FROM AAD 19

January 9, 2019 | Oncology Practice FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY